These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 36875062)

  • 21. Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies.
    Bajic G; van der Poel CE; Kuraoka M; Schmidt AG; Carroll MC; Kelsoe G; Harrison SC
    Sci Rep; 2019 Mar; 9(1):3492. PubMed ID: 30837606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin.
    Tan GS; Lee PS; Hoffman RM; Mazel-Sanchez B; Krammer F; Leon PE; Ward AB; Wilson IA; Palese P
    J Virol; 2014 Dec; 88(23):13580-92. PubMed ID: 25210195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses.
    Shen C; Chen J; Li R; Zhang M; Wang G; Stegalkina S; Zhang L; Chen J; Cao J; Bi X; Anderson SF; Alefantis T; Zhang M; Cai X; Yang K; Zheng Q; Fang M; Yu H; Luo W; Zheng Z; Yuan Q; Zhang J; Wai-Kuo Shih J; Kleanthous H; Chen H; Chen Y; Xia N
    Sci Transl Med; 2017 Oct; 9(412):. PubMed ID: 29046433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative analyses of all influenza type A viral hemagglutinins and neuraminidases using universal antibodies in simple slot blot assays.
    Gravel C; Li C; Wang J; Hashem AM; Jaentschke B; Van Domselaar G; He R; Li X
    J Vis Exp; 2011 Apr; (50):. PubMed ID: 21490585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice.
    Asthagiri Arunkumar G; Ioannou A; Wohlbold TJ; Meade P; Aslam S; Amanat F; Ayllon J; García-Sastre A; Krammer F
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Broadly Protective CD8
    Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S
    J Virol; 2021 May; 95(12):. PubMed ID: 33827939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses.
    Iba Y; Fujii Y; Ohshima N; Sumida T; Kubota-Koketsu R; Ikeda M; Wakiyama M; Shirouzu M; Okada J; Okuno Y; Kurosawa Y; Yokoyama S
    J Virol; 2014 Jul; 88(13):7130-44. PubMed ID: 24719430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exposure of an occluded hemagglutinin epitope drives selection of a class of cross-protective influenza antibodies.
    Adachi Y; Tonouchi K; Nithichanon A; Kuraoka M; Watanabe A; Shinnakasu R; Asanuma H; Ainai A; Ohmi Y; Yamamoto T; Ishii KJ; Hasegawa H; Takeyama H; Lertmemongkolchai G; Kurosaki T; Ato M; Kelsoe G; Takahashi Y
    Nat Commun; 2019 Aug; 10(1):3883. PubMed ID: 31462639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
    Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA
    J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific Monoclonal Antibodies Targeting Unique HA Epitopes Block H7N9 Influenza A Viral Replication.
    Shen W; Wang Q; Wang Z; Liu M; Du Y; Yuan L; Han L; Smietanka K; Chen H; Xu S; Zhu Q
    J Virol; 2022 Sep; 96(18):e0123822. PubMed ID: 36037479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conserved stem fragment from H3 influenza hemagglutinin elicits cross-clade neutralizing antibodies through stalk-targeted blocking of conformational change during membrane fusion.
    Gong X; Yin H; Shi Y; Guan S; He X; Yang L; Yu Y; Kuai Z; Jiang C; Kong W; Wang S; Shan Y
    Immunol Lett; 2016 Apr; 172():11-20. PubMed ID: 26875772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of hemagglutinin targeted influenza virus neutralization.
    Brandenburg B; Koudstaal W; Goudsmit J; Klaren V; Tang C; Bujny MV; Korse HJ; Kwaks T; Otterstrom JJ; Juraszek J; van Oijen AM; Vogels R; Friesen RH
    PLoS One; 2013; 8(12):e80034. PubMed ID: 24348996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-neutralizing Anti-hemagglutinin Antibodies Isolated from Patients Infected with Avian Influenza A (H5N1) Virus.
    Sun Y; Cao Y; Li Z; Bai T; Zhang H; Hu SX; Li FC; Zhao X; Chen YK; Lu J; Liu LQ; Wang DY; Shu YL; Zhou JF
    Biomed Environ Sci; 2020 Feb; 33(2):103-113. PubMed ID: 32131957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Linear Peptide Immunogens with Verified Broad-spectrum Immunogenicity from the Conserved Regions within the Hemagglutinin Stem Domain of H1N1 Influenza Virus.
    Li S; Qiao Y; Xu Y; Li P; Nie J; Zhao Q; Chai W; Shi Y; Kong W; Shan Y
    Immunol Invest; 2022 Feb; 51(2):411-424. PubMed ID: 33078652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Immunogenetic Considerations Underlying B-Cell Biology in the Development of a Pan-Subtype Influenza A Vaccine Targeting the Hemagglutinin Stem.
    Andrews SF; Graham BS; Mascola JR; McDermott AB
    Cold Spring Harb Perspect Biol; 2018 Jul; 10(7):. PubMed ID: 28663207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of Influenza B Universal Vaccine Candidates Using the "Mosaic" Hemagglutinin Approach.
    Sun W; Kirkpatrick E; Ermler M; Nachbagauer R; Broecker F; Krammer F; Palese P
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30944178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of H7N9 hemagglutinin novel protein epitopes that elicit strong antibody-dependent, cell-mediated cytotoxic activities with protection from influenza infection in mouse model.
    Zhu P; Yi X; Zhang L; Liu Y; Wang S; Gu J; Zhu X; Yu X
    Cell Immunol; 2021 Jan; 359():104255. PubMed ID: 33316647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly conserved influenza T cell epitopes induce broadly protective immunity.
    Eickhoff CS; Terry FE; Peng L; Meza KA; Sakala IG; Van Aartsen D; Moise L; Martin WD; Schriewer J; Buller RM; De Groot AS; Hoft DF
    Vaccine; 2019 Aug; 37(36):5371-5381. PubMed ID: 31331771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Prevalent Focused Human Antibody Response to the Influenza Virus Hemagglutinin Head Interface.
    McCarthy KR; Lee J; Watanabe A; Kuraoka M; Robinson-McCarthy LR; Georgiou G; Kelsoe G; Harrison SC
    mBio; 2021 Jun; 12(3):e0114421. PubMed ID: 34060327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly conserved protective epitopes on influenza B viruses.
    Dreyfus C; Laursen NS; Kwaks T; Zuijdgeest D; Khayat R; Ekiert DC; Lee JH; Metlagel Z; Bujny MV; Jongeneelen M; van der Vlugt R; Lamrani M; Korse HJ; Geelen E; Sahin Ö; Sieuwerts M; Brakenhoff JP; Vogels R; Li OT; Poon LL; Peiris M; Koudstaal W; Ward AB; Wilson IA; Goudsmit J; Friesen RH
    Science; 2012 Sep; 337(6100):1343-8. PubMed ID: 22878502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.